Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Study for Evaluating Life Quality and Its Determinant Factors as Treatment Adherence and Immunotherapy Satisfaction in Patients With Rhinoconjunctivitis With or Without Asthma, Sensitized at Least to One Aeroallergen

NCT02488447 is registered in ClinicalTrials.gov with Roxall Medicina España S.A as lead sponsor.

NCT NCT02488447
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02488447 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Study for Evaluating Life Quality and Its Determinant Factors as Treatment Adherence and Immunotherapy Satisfaction in Patients With Rhinoconjunctivitis With or Without Asthma, Sensitized at Least to One Aeroallergen
Lead sponsor
Roxall Medicina España S.A
Phase
Observational
Overall status
Completed
Start date
May 31, 2015
Completion date
May 25, 2017
Enrollment
215 (actual)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

allergic rhinoconjunctivitis